|Articles|August 4, 2016
New CEO for Inspyr Therapeutics
August 04, 2016
Advertisement
Inspyr Therapeutics, Inc. (San Antonio, TX) has appointed Christopher Lowe as President and Chief Executive Officer, and as a member of the Company’s Board of Directors. Mr. Lowe brings more than 15 years of executive management experience in life sciences as CEO, Chief Financial Officer and Chief Business Officer, and has been an advisor to the Inspyr’s Board of Directors since March 2016.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
4
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
5